XML 43 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Note 1 - Organization (Details Textual) - USD ($)
1 Months Ended 2 Months Ended 12 Months Ended
Jan. 31, 2020
Aug. 26, 2019
Nov. 01, 2018
Jul. 16, 2018
Feb. 16, 2018
Feb. 14, 2018
Jan. 31, 2020
May 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Jul. 13, 2018
Dec. 31, 2017
Retained Earnings (Accumulated Deficit), Ending Balance                 $ (348,335,000) $ (328,885,000)    
Cash and Cash Equivalents, at Carrying Value, Ending Balance                 10,943,000 16,410,000   $ 5,389,000
Proceeds from Issuance or Sale of Equity, Net         $ 15,500,000              
Proceeds from Warrant Exercises               $ 8,000,000 $ 7,993,000 $ 581,000    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights         1,797,900              
Preferred Stock, Par or Stated Value Per Share         $ 0.001       $ 0.001 $ 0.001    
Debt Conversion, Original Debt, Amount                 $ 42,794,000    
Share Price                 $ 1.14      
CRG [Member] | Conversion of Principal Amount of Senior Secured Loan to Newly Authorized Series A Preferred Stock [Member]                        
Debt Conversion, Original Debt, Amount         $ 38,000,000 $ 38,000,000            
Debt Conversion, Converted Instrument, Amount         $ 41,800,000 $ 41,800,000            
Common Stock Warrants, Issued with Series B Preferred Stock, Warrant One [Member]                        
Class of Warrant or Right, Number of Warrants Issued for Each Share of Preferred Stock         1              
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right         50              
Class of Warrant or Right, Contingent Expiration Period Following Initial Exercise Date         7 years              
Class of Warrant or Right, Exercise Price of Warrants or Rights         $ 4              
Common Stock Warrants, Issued with Series B Preferred Stock, Warrant Two [Member]                        
Class of Warrant or Right, Number of Warrants Issued for Each Share of Preferred Stock         1              
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right         50              
Class of Warrant or Right, Contingent Expiration Period Following Initial Exercise Date         7 years              
Class of Warrant or Right, Expiration Period Following FDA Clearance         60 days              
Series C Preferred Stock [Member]                        
Proceeds from Issuance or Sale of Equity, Net     $ 10,200,000                  
Stock Issued During Period, Shares, New Issues     8,586                  
Preferred Stock, Par or Stated Value Per Share     $ 0.001                  
Series B Preferred Stock [Member]                        
Stock Issued During Period, Shares, New Issues         17,979              
Preferred Stock, Par or Stated Value Per Share         $ 0.001              
Series A Preferred Stock [Member]                        
Stock Issued During Period, Shares, New Issues         41,800              
Series A Preferred Stock [Member] | Conversion of Principal Amount of Senior Secured Loan to Newly Authorized Series A Preferred Stock [Member]                        
Convertible Preferred Stock, Shares of Common Stock Issuable on Conversion         2,090,000 2,090,000            
January 2020 Public Offering [Member] | Subsequent Event [Member]                        
Proceeds from Issuance or Sale of Equity, Net $ 3,700,000           $ 3,700,000          
Stock Issued During Period, Shares, New Issues 6,428,572                      
Share Price $ 0.70           $ 0.70          
August Public Offering [Member]                        
Proceeds from Issuance or Sale of Equity, Net   $ 3,800,000                    
Stock Issued During Period, Shares, New Issues   3,813,559                    
Share Price   $ 1.18                    
November Public Offering [Member]                        
Stock Issued During Period, Shares, New Issues     728,500                  
November Public Offering [Member] | Common Stock Warrants [Member]                        
Proceeds from Warrant Exercises                 $ 8,000,000      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     2,875,000                  
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right     1                  
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 4                  
November Public Offering [Member] | Series C Preferred Stock [Member]                        
Proceeds from Issuance or Sale of Equity, Net     $ 10,200,000                  
Stock Issued During Period, Shares, New Issues     8,586                  
Placement Agency Sale - Prospectus Supplement of July 12, 2018 [Member]                        
Proceeds from Issuance or Sale of Equity, Net       $ 3,000,000                
Sale of Stock, Consideration Received on Transaction       $ 3,000,000                
Placement Agency Sale - Prospectus Supplement of July 12, 2018 [Member] | Common Stock Warrants [Member]                        
Stock Issued During Period, Shares, New Issues       216,618                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       108,309             108,309  
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right       1                
Shares Issued, Price Per Share       $ 16.425                
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 15.80             $ 15.80